Skip to main content
Signal8

Rotunno Mary L.

SEC insider (Form 3/4/5 filer). CIK 0001869200. Director at Vistagen Therapeutics, Inc. (VTGN). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2025. Located in SOUTH SAN FRANCISCO, CA.

Companies Rotunno Mary L. has filed insider reports for

  • Vistagen Therapeutics, Inc. (VTGN): Director
Rotunno Mary L. profile photo

Rotunno Mary L.

CIK: 0001869200

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Vistagen Therapeutics, Inc. logo
VTGN

Vistagen Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Vistagen Therapeutics, Inc. logo
    VTGN

    Vistagen Therapeutics, Inc.

    Sep 9, 2025
    Award

    Non-Qualified Stock Option (right to buy)

    Direct
    17.6K shares-
  • Vistagen Therapeutics, Inc. logo
    VTGN

    Vistagen Therapeutics, Inc.

    Sep 6, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    14.1K shares-

1-2 of 2